MILLENNIUM MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$208,718
+16.9%
139,145
+23.9%
0.00%
Q2 2023$178,598
+112225.8%
112,326
-49.2%
0.00%
Q1 2023$159
-23.9%
220,985
-38.8%
0.00%
Q4 2022$209
-100.0%
361,101
-58.2%
0.00%
Q3 2022$820,000
-34.2%
863,421
-16.9%
0.00%
-100.0%
Q2 2022$1,246,000
+2939.0%
1,038,458
+4390.6%
0.00%
Q4 2021$41,000
-97.6%
23,125
-97.0%
0.00%
-100.0%
Q3 2021$1,681,000
+4102.5%
774,852
+6642.5%
0.00%
Q2 2021$40,000
-85.8%
11,492
-55.8%
0.00%
Q4 2020$282,000
-84.7%
25,987
-85.5%
0.00%
-100.0%
Q3 2020$1,841,000
-67.7%
178,779
-34.5%
0.00%
-75.0%
Q2 2020$5,699,000
+54.3%
272,957
-27.8%
0.01%0.0%
Q1 2020$3,693,000
+1471.5%
378,014
+1756.2%
0.01%
Q4 2019$235,000
-16.4%
20,365
-77.2%
0.00%
Q4 2018$281,000
-71.9%
89,216
-46.0%
0.00%
-100.0%
Q3 2018$1,000,000
+21.5%
165,348
+6.5%
0.00%0.0%
Q2 2018$823,000
-91.5%
155,216
-90.7%
0.00%
-92.3%
Q1 2018$9,676,000
+1045.1%
1,668,299
+591.0%
0.01%
+1200.0%
Q4 2017$845,000
-7.0%
241,422
-3.1%
0.00%0.0%
Q3 2017$909,000
-38.4%
249,026
-57.8%
0.00%
-66.7%
Q2 2017$1,475,000
+87.7%
590,164
+102.7%
0.00%
+200.0%
Q1 2017$786,000
-20.1%
291,125
-14.2%
0.00%
-50.0%
Q4 2016$984,000
+1908.2%
339,471
+2742.9%
0.00%
Q3 2016$49,000
-84.2%
11,941
-87.8%
0.00%
-100.0%
Q2 2016$310,00098,1000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders